Non-adherence - ASCVD & Lipidology Knowledge Hub

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm
  • Share

  • Stay up to date
  • Home
  • Topics
    • Cardiovascular Diseases and Conditions
      • Acute Coronary Syndrome
      • Atherosclerosis
      • Coronary artery disease
      • CVD
      • ASCVD
      • Myocardial Infarction
    • Lipid Metabolism and Disorders
      • Lipids
        • PUFA
          • Eicosanoids
      • Cholesterol
        • High-density lipoprotein
        • Low-density lipoprotein
        • Low-density Lipoprotein Cholesterol
        • Lipoprotein (a)
        • Apolipoprotein B
        • Hypercholesterolemia
        • Hyperlipidemia
        • Dyslipidemia
        • Familial hypercholesterolemia
      • Triglycerides
      • Cholesterol synthesis
      • Cholesterol absorption
    • Medications and Therapies
      • Therapy
      • Lipid lowering therapy
        • Statin
          • High-intensity statin
        • PCSK9
          • Alirocumab
          • Evolocumab
        • Bempedoic acid
        • Icosapent Ethyl
        • Inclisiran
        • Obicetrapib
        • Zerlasiran
      • Combination therapy
      • Aspirin
      • Immunotherapy
      • Short interfering RNA (siRNA)
      • Diabetes
    • Risk Factors and Prevention
      • CVD Risk Factor
      • Primary prevention
      • Prevention
      • Risk assessment
      • Women
      • Inflammation
      • Calcium Scoring
    • Clinical Research and Guidelines
      • Clinical Trial
      • Trials
      • Guidelines
      • Consensus statement
      • Registry
      • GOULD
    • Other Related Topics
      • Congresses
      • Global health
      • Vaccination
        • Influenza
      • Non-adherence
      • Pediatric Population
      • Plaques
      • Obesity
    • Molecular and Genetic Factors
      • ANGPTL3
  • Webinars/Videos
  • Infographics
  • Articles
  • Case Studies
  • Forum
  • Faculty
  • Unblocked
  • Stay up to date

Non-adherence

Infographics

  • Infographics

    Treatment Persistence and Non-Adherence in Atherosclerotic Cardiovascular Disease

    Unlock the key to optimizing patient outcomes in atherosclerotic cardiovascular disease with our insightful infographic, which delves into the critical challenges of treatment persistence and non-adherence, offering healthcare professionals actionable strategies for effective clinical management.

    View
    • Share

How would you rate this content?

  • © John Wiley & Sons, Ltd. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Stay up to date
  • Cookie Preferences
  • This Knowledge Hub is supported by Novartis.
Clinical Cardiology